semaglutide compound law The Risks of Compounded Products FDA Crackdown on Compounded GLP-1
Description
They received 12 mg once weekly retatrutide injections subcutaneously for 12 weeks
There are no clinical trials demonstrating weight loss from this specific product
48 MichelP
Both are recommended by doctors alongside diet and exercise to support safe and effective weight loss
Early clinical trials have shown large, dose-related weight loss in people with obesity
In some cases, dehydration from severe nausea, vomiting, or diarrhea (common early side effects of semaglutide) can strain the kidneys, especially in those with compromised kidney function
